These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2304 related articles for article (PubMed ID: 6806475)

  • 1. Antitumor agents. 2. Bisguanylhydrazones of anthracene-9,10-dicarboxaldehydes.
    Murdock KC; Child RG; Lin Y; Warren JD; Fabio PF; Lee VJ; Izzo PT; Lang SA; Angier RB; Citarella RV; Wallace RE; Durr FE
    J Med Chem; 1982 May; 25(5):505-18. PubMed ID: 6806475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, DNA-damaging and cytotoxic properties of novel topoisomerase II-directed bisantrene analogues.
    Zagotto G; Oliva A; Guano F; Menta E; Capranico G; Palumbo M
    Bioorg Med Chem Lett; 1998 Jan; 8(2):121-6. PubMed ID: 9871638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-disubstituted anthracene antitumor agents.
    Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
    J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
    Stefanska B; Dzieduszycka M; Martelli S; Borowski E
    J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
    Murdock KC; Child RG; Fabio PF; Angier RB; Wallace RE; Durr FE; Citarella RV
    J Med Chem; 1979 Sep; 22(9):1024-30. PubMed ID: 490545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT; Garcia D; Peng YM; Alberts DS
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antitumor agents containing the anthracene nucleus.
    Wunz TP; Dorr RT; Alberts DS; Tunget CL; Einspahr J; Milton S; Remers WA
    J Med Chem; 1987 Aug; 30(8):1313-21. PubMed ID: 2441053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene.
    Bowden GT; Roberts R; Alberts DS; Peng YM; Garcia D
    Cancer Res; 1985 Oct; 45(10):4915-20. PubMed ID: 4027978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding abilities of bisguanylhydrazones of anthracene-9,10-dicarboxaldehyde.
    Foye WO; Karnik PS; Sengupta SK
    Anticancer Drug Des; 1986 Apr; 1(2):65-71. PubMed ID: 2453195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
    Wallace RE; Murdock KC; Angier RB; Durr FE
    Cancer Res; 1979 May; 39(5):1570-4. PubMed ID: 427798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H
    Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
    Lown JW; Hanstock CC; Bradley RD; Scraba DG
    Mol Pharmacol; 1984 Jan; 25(1):178-84. PubMed ID: 6708933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed-phase high-performance liquid chromatographic assay for the antineoplastic agent 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl hydrazone) dihydrochloride.
    Powis G
    J Chromatogr; 1981 Dec; 226(2):514-20. PubMed ID: 7320182
    [No Abstract]   [Full Text] [Related]  

  • 16. N-phosphoryl derivatives of bisantrene. Antitumor prodrugs with enhanced solubility and reduced potential for toxicity.
    Murdock KC; Lee VJ; Citarella RV; Durr FE; Nicolau G; Kohlbrenner M
    J Med Chem; 1993 Jul; 36(15):2098-101. PubMed ID: 8340913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
    Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
    J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
    Powis G; Kovach JS
    Cancer Res; 1983 Feb; 43(2):925-9. PubMed ID: 6848203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of 9, 10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride.
    Lu K; Savaraj N; Yap BS; Feun LG; Umsawasdi T; Loo TL
    Cancer Chemother Pharmacol; 1986; 16(2):156-9. PubMed ID: 3948302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones.
    Krapcho AP; Landi JJ; Hacker MP; McCormack JJ
    J Med Chem; 1985 Aug; 28(8):1124-6. PubMed ID: 4020835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.